BURKITT LYMPHOMA
Clinical trials for BURKITT LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new BURKITT LYMPHOMA trials appear
Sign up with your email to follow new studies for BURKITT LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Experimental stem cell therapy aims to speed recovery in blood cancer patients
Disease control OngoingThis study tests a new way to grow stem cells from umbilical cord blood to help people with high-risk blood cancers like leukemia and lymphoma recover faster after a bone marrow transplant. About 22 patients will receive the expanded stem cells along with standard chemotherapy an…
Matched conditions: BURKITT LYMPHOMA
Phase: PHASE2 • Sponsor: Masonic Cancer Center, University of Minnesota • Aim: Disease control
Last updated May 26, 2026 11:07 UTC
-
New combo therapy targets tough lymphoma
Disease control OngoingThis early-phase trial tests a new drug, loncastuximab tesirine, combined with standard chemotherapy (DA-EPOCH-R) in 11 adults with aggressive B-cell lymphoma. The goal is to find the safest dose and see if the combination can control the disease. Participants must have certain t…
Matched conditions: BURKITT LYMPHOMA
Phase: PHASE1 • Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated May 19, 2026 12:01 UTC
-
New antibody drug shows promise in early cancer trial
Disease control OngoingThis early-stage study tests a new drug called IMT-009 in people with advanced solid tumors or lymphomas that have not responded to standard treatments. The main goals are to find a safe dose and learn about side effects. About 67 participants will receive the drug intravenously,…
Matched conditions: BURKITT LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: Immunitas Therapeutics • Aim: Disease control
Last updated May 18, 2026 12:08 UTC